These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16357092)

  • 21. Good science or good marketing?
    Head K
    Altern Med Rev; 2002 Aug; 7(4):274-5. PubMed ID: 12197780
    [No Abstract]   [Full Text] [Related]  

  • 22. A plea for women.
    White M
    Menopause Int; 2011 Mar; 17(1):31. PubMed ID: 21427424
    [No Abstract]   [Full Text] [Related]  

  • 23. Managing postmenopausal vaginal atrophy. Vaginal dryness is one of the most irritating symptoms of menopause. Here are some ways to relieve it.
    Harv Womens Health Watch; 2010 Mar; 17(7):4-5. PubMed ID: 20480969
    [No Abstract]   [Full Text] [Related]  

  • 24. From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health.
    Gambacciani M; Genazzani AR
    Gynecol Endocrinol; 2006 Mar; 22(3):115-6. PubMed ID: 16835071
    [No Abstract]   [Full Text] [Related]  

  • 25. Hormone replacement therapy and atherosclerosis in postmenopausal women: does aging limit therapeutic benefits?
    Barton M; Meyer MR; Haas E
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1669-72. PubMed ID: 17634518
    [No Abstract]   [Full Text] [Related]  

  • 26. The trials and tribulations of long-term postmenopausal hormone therapy.
    MacLennan AH
    Obstet Gynecol Surv; 2004 Feb; 59(2):65-7. PubMed ID: 14752298
    [No Abstract]   [Full Text] [Related]  

  • 27. Hormone replacement therapy and coronary artery disease: buried alive?
    Bahl VK; Naik N
    Indian Heart J; 2002; 54(1):23-30. PubMed ID: 11999084
    [No Abstract]   [Full Text] [Related]  

  • 28. The applicability of hormonal effects on atherosclerosis in animals to heart disease in postmenopausal women.
    Wagner JD; Clarkson TB
    Semin Reprod Med; 2005 May; 23(2):149-56. PubMed ID: 15852200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone replacement therapy aggravates postmenopausal urinary incontinence.
    Prescrire Int; 2006 Aug; 15(84):137-8. PubMed ID: 16989027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New developments in postmenopausal hormone replacement therapy.
    Prelevic GM; Jacobs HS
    Curr Opin Obstet Gynecol; 1997 Jun; 9(3):207-12. PubMed ID: 9263706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF; Oger E
    Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone therapy: the next chapter. Is it time to rewrite the book on postmenopausal hormone use?
    Harv Womens Health Watch; 2011 Mar; 18(7):1-3. PubMed ID: 21526525
    [No Abstract]   [Full Text] [Related]  

  • 33. Hormones, menopause, and heart disease: making sense of the Women's Health Initiative.
    Derry PS
    Womens Health Issues; 2004; 14(6):212-9. PubMed ID: 15589771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
    Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical comments.
    Samsioe G; Neves-e-Castro M; Pines A; Doeren M; Utian WH; Jaffe RB; Genazzani AR; van der Mooren MJ
    Maturitas; 2001 Oct; 40(1):5-15. PubMed ID: 11684369
    [No Abstract]   [Full Text] [Related]  

  • 36. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
    Mohandas B; Mehta JL
    Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women.
    Tracer H; McKee DL
    Am Fam Physician; 2018 Apr; 97(8):541-542. PubMed ID: 29671495
    [No Abstract]   [Full Text] [Related]  

  • 38. Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review.
    Abramson BL
    J Cardiovasc Risk; 2002 Dec; 9(6):309-14. PubMed ID: 12478199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A decade of postmenopausal hormone therapy prescribing in the United States: long-term effects of the Women's Health Initiative.
    Steinkellner AR; Denison SE; Eldridge SL; Lenzi LL; Chen W; Bowlin SJ
    Menopause; 2012 Jun; 19(6):616-21. PubMed ID: 22648302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.